Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Pumpkin seed oil helps hair growth in men with hair loss.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Finasteride and dutasteride do not significantly change beard thickness in men.